简化乳腺磁共振成像(MRI)或数字乳腺断层合成在致密乳腺中检测乳腺癌?一项结果可比的回顾性初步研究
该单中心横断面研究纳入115例乳腺密度为C或D且行简化乳腺MRI(AB-MR)的女性,以组织病理为参考标准比较AB-MR与数字乳腺断层合成(DBT)对164个病灶的检出效能;DBT与AB-MR敏感度均为98.5%,AB-MR特异度43.9%高于DBT的34.6%,两者对低风险病灶均有高阴性预测值。
要点
- DBT与AB-MR对致密乳腺乳腺癌检出敏感度均为98.5%,AB-MR特异度43.9%高于DBT的34.6%。
- AB-MR漏诊1个低级别导管原位癌(DCIS),占恶性病灶0.6%。
- DBT未检出61个病灶,其中46个(75.4%)位于密度C乳腺。
核心结论
- 研究结果提示,DBT与AB-MR作为致密乳腺女性乳腺癌检测方法效能相当,且对低风险病灶均有高阴性预测值。
研究设计与样本
- 单中心横断面研究,纳入2018年6月至2021年12月间115例DBT乳腺密度为ACR BI-RADS C或D且伴乳腺病灶并接受AB-MR的女性。
- AB-MR在3 T MRI系统上进行,成像方案包括三个序列:轴位T1脂肪饱和平扫、轴位首期增强扫描、以及首期增强减影最大强度投影(MIP)。
- DBT与AB-MR图像由两名对组织病理和患者结局设盲的放射科医生评估,以组织病理为参考标准。
关键影像表现/征象
- 164个组织病理证实病灶中69个(42.1%)为恶性、95个(57.9%)为良性。
- DBT检出62.8%(103/164)病灶,检出全部恶性病灶100%(69/69)及35.7%(34/95)良性病灶。
- AB-MR检出65.2%(107/164)病灶,检出98.6%(68/69)恶性病灶及41.1%(39/95)良性病灶。
- 未检出61个病灶中46个(75.4%)位于密度C乳腺、15个(24.6%)位于密度D乳腺。
诊断标准与关键数值
- DBT敏感度98.5%、特异度34.6%、阳性预测值66.3%、阴性预测值94.7%。
- AB-MR敏感度98.5%、特异度43.9%、阳性预测值67.2%、阴性预测值96.2%。
- AB-MR漏诊1个恶性病灶(0.6%),为低级别导管原位癌(DCIS)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文标题注明为回顾性初步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To compare the diagnostic performance of abbreviated breast magnetic resonance (AB-MR) imaging (MRI) and digital breast tomosynthesis (DBT) for breast cancer detection in Malaysian women with dense breasts, using histopathology as the reference standard.
MATERIALS AND METHODS: This was a single-centre cross-sectional study of 115 women with American College of Radiology (ACR) Breast Imaging-Reporting and Data System (BIRADS) breast density C and D on DBT with breast lesions who underwent AB-MR from June 2018 to December 2021. AB-MR was performed on a 3 T MRI system with an imaging protocol consisting of three sequences: axial T1 fat-saturated unenhanced; axial first contrast-enhanced; and subtracted first contrast-enhanced with maximum intensity projection (MIP). DBT and AB-MR images were evaluated by two radiologists blinded to the histopathology and patient outcomes. Diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV] and negative predictive value [NPV]) was assessed.
RESULT: Of the 115 women, the mean age was 50.6 years. There were 48 (41.7%) Malay, 54 (47%) Chinese, and 12 (10.4%) Indian women. The majority (n=87, 75.7%) were from the diagnostic population. Sixty-one (53.1%) were premenopausal and 54 (46.9%) postmenopausal. Seventy-eight (72.4%) had an increased risk of developing breast cancer. Ninety-one (79.1%) women had density C and 24 (20.9%) had density D. There were 164 histopathology-proven lesions; 69 (42.1%) were malignant and 95 (57.9%) were benign. There were 62.8% (n=103/164) lesions detected at DBT. All the malignant lesions 100% (n=69) and 35.7% (n=34) of benign lesions were detected. Of the 61 lesions that were not detected, 46 (75.4%) were in density C, and 15 (24.6%) were in density D. The sensitivity, specificity, PPV, and NPV for DBT were 98.5%, 34.6%, 66.3%, and 94.7%, respectively. There were 65.2% (n=107/164) lesions detected on AB-MR, with 98.6% (n=68) malignant and 41.1% (39) benign lesions detected. The sensitivity, specificity, PPV, and NPV for AB-MR were 98.5%, 43.9%, 67.2%, and 96.2%, respectively. One malignant lesion (0.6%), which was a low-grade ductal carcinoma in-situ (DCIS), was missed on AB-MR.
CONCLUSION: The present findings suggest that both DBT and AB-MR have comparable effectiveness as an imaging method for detecting breast cancer and have high NPV for low-risk lesions in women with dense breasts.
引用
- Ramli Hamid MT, Ab Mumin N, Abdul Hamid S, et al. Abbreviated breast magnetic resonance imaging (MRI) or digital breast tomosynthesis for breast cancer detection in dense breasts? A retrospective preliminary study with comparable results. Clin Radiol. 2024. PMID: 38267349. doi:10.1016/j.crad.2023.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。